Weighing the cost of technology advances in medical devices
A New York Times op-ed entitled “In Cancer Care, Cost Matters,” described what may be one of the earliest accounts where doctors at Sloan-Kettering decided not to use a new cancer drug because of its extra cost when they were already using equally-effective drugs for their cancer treatments. The article piqued my interest. These days for any doctor who uses expensive technologies, it is easy to see where this evaluation …